Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore

Citation
A. Seow et al., Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore, CARCINOGENE, 22(4), 2001, pp. 673-677
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
22
Issue
4
Year of publication
2001
Pages
673 - 677
Database
ISI
SICI code
0143-3334(200104)22:4<673:CP(AAL>2.0.ZU;2-Z
Abstract
There is increasing evidence for the role of heterocyclic and other arylami nes in carcinogenesis, including lung carcinogenesis. Chinese women have a high rate of lung cancer despite a low smoking prevalence, and studies in t his population may provide useful information on risk factors other than sm oking. Hepatic CYP1A2 and NAT2 are involved in the metabolism of carcinogen ic arylamines, and NAT2 also catalyzes the detoxification pathway for these compounds. In this study, we examined the effect of CYP1A2 activity using a urinary caffeine metabolic ratio assay for 54 Chinese women with newly di agnosed lung cancer (including 28 adenocarcinomas) and 174 hospital control s. Among them, NAT2 genotype was available for 47 cases and 98 controls. Th ere was no effect of CYP1A2 activity on overall risk of lung cancer in the study population [odds ratio (OR) 0.8, 95% confidence interval (CI) 0.4-1.6 , adjusted for age at diagnosis, smoking and cruciferous vegetable intake]. For adenocarcinomas, the OR was 1.5, 95% CI 0.6-3.4, After further adjustm ent for NAT2 acetylator genotype, the OR for adenocarcinoma was 1.8 (95% CI 0,7-4,8), When the combined NAT2/CYP1A2: status was examined, women with s low NAT2 and rapid CYP1A2 activity were at highest risk (adjusted OR 6,9, 9 5% CI 1.3-37.6) relative to women with rapid NAT2 and slow CYP1A2 activity, for lung adenocarcinoma, While larger studies are needed to confirm or ref ute these results, they are consistent with a role for heterocyclic arylami nes in lung carcinogenesis in this primarily non-smoking population.